Phibro Animal Health Corp. (PAHC) PT Raised to $25 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts PAHC Hot Sheet
Price: $39.37 +4.57%
Rating Summary:
4 Buy, 6 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
4 Buy, 6 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Morgan Stanley analyst Erin Wright raised the price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $25.00 (from $20.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Phibro Animal Health Corporation Declares Quarterly Dividend
- Cinemark Holdings (CNK) PT Raised to $45 at StoneX
- Red Rock Resorts (RRR) PT Lowered to $60 at StoneX
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
